menu search

Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)

– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, spec...

October 10, 2023, 11:30 am

Fibrin sealants market size to hit usd 2 billion in 2031, to expand at a cagr of 6.7% – exclusive report by transparency market research

The evolution of modern surgical procedures has been significantly shaped by the global demand for adequate hemo...

October 10, 2023, 11:30 am

Mirum pharmaceuticals: an attractive stock to watch for its liver disease franchise

Mirum Pharmaceuticals has two drugs, maralixibat and volixibat, targeting rare liver diseases involving choles...

September 24, 2023, 3:51 am

Apollomics: a taiwanese-origin company with late stage pipeline

Apollomics is a small company with a pipeline of c-Met targeting small molecule TKIs for various cancers. Their lead candidate, Vebreltinib, is in pha...

August 29, 2023, 6:21 am

Astrazeneca's (azn) lynparza gets expanded use nod in japan

AstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to treat adult patients with BRCA-mutated castration-res...

August 25, 2023, 1:32 pm

Biocept cnside assay takes the spotlight at 2023 sno/asco cns cancer conference

Biocept Inc (NASDAQ:BIOC) said that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 Society for Neuro-Oncology...

August 14, 2023, 8:40 am

Genfit shares fall despite positive trial results for rare cholestatic liver disease therapeutic

GENFIT (NASDAQ:GNFT) shares fell 5% after initially rising on positive results from its clinical trial with partner Ipsen for the investigational the...

June 30, 2023, 10:46 am

Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at the 83rd american diabetes association scientific sessions

– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic control with a favorable tolerability profile over a...

June 24, 2023, 1:30 am

Moderna and merck reveal new data on individualized cancer treatment

Moderna MRNA, +1.55% and Merck & Co. MRK, +1.43% on Monday released new results from a trial evaluating Moderna's mRNA-based investigational individua...

June 5, 2023, 9:19 am

Bitcoin in stasis below $27k ahead of powell speech

U.S. Federal Reserve Chairman Jerome Powell will speak late Friday morning at the “Perspectives on Monetary Policy” panel before the Thomas Laubac...

May 19, 2023, 1:44 pm

Here's why you should invest in haemonetics (hae) right now

Investors are upbeat about Haemonetics (HAE) owing to impressive Plasma and Hospital business performance, with continued strength in the Hemo...

April 4, 2023, 1:42 pm

Y-mabs therapeutics receives 'neutral' stance from wedbush after fda rejection of its pediatric cancer drug application

Broker Wedbush has repeated a 'neutral' stance on biopharma Y-mAbs Therapeutics Inc (NASDAQ:YMAB) following news that the US Food and Drug Administrat...

December 2, 2022, 10:36 am

Biocept reports 176% year-over-year jump in orders for cnside assay

Biocept Inc (NASDAQ:BIOC) has reported a 176% year-over-year jump in orders for its CNSide product, a cerebrospinal fluid assay addressing unmet need...

November 21, 2022, 4:53 pm

Biocept to use cnside assay in study looking at biomarkers in patients with metastatic breast cancer

Biocept Inc (NASDAQ:BIOC) said it is participating in a study evaluating biomarkers associated with central nervous system (CNS) meta...

November 16, 2022, 9:27 am

Aldeyra therapeutics: poised for dry eye disease therapy monetization

Reproxalap seems poised for FDA approval for dry eye disease. Therapy has clear practical advantages over Rest...

August 4, 2022, 2:25 am

Prophase labs: a growth stock at an attractive valuation

ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemo...

July 25, 2022, 5:57 pm

Volitionrx presents data related to its nets research at isth congress

VolitionRx (NYSE-A:VNRX) Limited announced it had presented data about its work on neutrophil extracellular traps, or NETs, at the International Socie...

July 13, 2022, 10:30 am

Albireo: a speculative play with upside

The lead medicine (Bylvay) is already approved to treat an orphan disease known as progressive familial intrahepatic chole...

May 3, 2022, 2:06 pm

Angle technology used in metastatic breast cancer research

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said its liquid biopsy system was central to research carried out by scientists attempting to understand why breast c...

April 1, 2022, 2:57 am

Viatris (vtrs) gets fda nod for generic drug in dry eye disease

Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Re...

February 4, 2022, 1:45 pm


Search within

Pages Search Results: